The novel
thiol-group-selective bifunctional 18F-labeling agent N-[6-(4-[18F]fluoro-benzylidene)aminooxyhexyl]
maleimide ([
18F]FBAM) has been developed. The bifunctional labeling precursor N-(6-aminoxyhexyl)maleimide containing a
thiol-reactive
maleimide group and a carbonyl-group-reactive aminooxy group was prepared in only three steps in a total chemical yield of 59%. Subsequent radiolabeling with 4-[18F]fluorobenzaldehyde gave the bifunctional 18F-labeling agent [
18F]FBAM in a radiochemical yield of 29%. In a typical experiment, 3.88 GBq of [18F]
fluoride could be converted into 723 MBq of [
18F]FBAM within 69 min. Conjugation of [
18F]FBAM with
thiol groups was exemplified with the
cysteine-containing tripeptide
glutathione and with various
apolipoproteins of human
low-density lipoprotein (
LDL) subfractions. The latter was evaluated with respect to the uptake of [
18F]FBAM-
LDL subfractions in human
hepatoma cells (HepG2) in vitro. In vivo biodistribution studies in rats revealed high stability for [
18F]FBAM-
LDL subfractions. Moreover, the metabolic fate of [
18F]FBAM-
LDL subfractions in vivo was delineated by dynamic positron emission tomography studies using a dedicated small animal tomograph. Data were compared to former studies that used the NH2-reactive 18F-labeling agent N-succinimidyl-4-[18F]fluorobenzoate. The compound [
18F]FBAM can be considered as an excellent prosthetic group for the selective and mild 18F labeling of
thiol-group-containing biomolecules suitable for subsequent investigations in vitro and in vivo.